can semaglutide cause fatty liver Why are GLP-1 agonists being used to treat patients with nonalcoholic disease? New Developments in Treating Fatty

STICH is one such protocol: STop the SGLT2 inhibitor, Inject bolus insulin, Consume 30 g carbohydrates and Hydrate

doi: 10.1111/dom.14566 [DOI] [PMC free article] [PubMed] [Google Scholar] 55

A population-based cohort study of nearly 114,000 patients with T2D found that use of GLP-1s, compared with SGLT-2 inhibitors, was associated with a 27% higher relative risk of being diagnosed with GERD and a 55% higher relative risk of GERD-related complications

We conducted several additional analyses

Weight Loss Benefits While not its primary indication, Ozempic users often experience significant weight loss as a secondary benefit